Citadel Advisors LLC purchased a new position in shares of NCS Multistage Holdings Inc (NASDAQ:NCSM) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 14,521 shares of the company’s stock, valued at approximately $350,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Nationwide Fund Advisors purchased a new position in NCS Multistage during the 2nd quarter worth approximately $157,000. Strs Ohio grew its stake in shares of NCS Multistage by 131.3% during the 3rd quarter. Strs Ohio now owns 7,400 shares of the company’s stock worth $178,000 after purchasing an additional 4,200 shares during the period. Alliancebernstein L.P. acquired a new stake in shares of NCS Multistage during the 2nd quarter worth approximately $201,000. The Manufacturers Life Insurance Company acquired a new stake in shares of NCS Multistage during the 2nd quarter worth approximately $211,000. Finally, Parametric Portfolio Associates LLC acquired a new stake in shares of NCS Multistage during the 2nd quarter worth approximately $257,000. 93.02% of the stock is owned by institutional investors.

A number of brokerages have recently commented on NCSM. Zacks Investment Research cut shares of NCS Multistage from a “buy” rating to a “sell” rating in a research note on Saturday, November 18th. Raymond James Financial raised shares of NCS Multistage from an “outperform” rating to a “strong-buy” rating in a research note on Wednesday, November 15th. UBS raised shares of NCS Multistage from an “outperform” rating to a “strong-buy” rating in a research note on Wednesday, November 15th. Credit Suisse Group dropped their price objective on shares of NCS Multistage from $27.00 to $23.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 15th. Finally, Wells Fargo & Company reaffirmed an “outperform” rating and set a $30.00 price objective (down previously from $35.00) on shares of NCS Multistage in a research note on Wednesday, November 15th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and two have given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $27.43.

Shares of NCS Multistage Holdings Inc (NASDAQ:NCSM) opened at $15.29 on Thursday. NCS Multistage Holdings Inc has a one year low of $13.85 and a one year high of $29.07. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.31 and a quick ratio of 2.29.

NCS Multistage (NASDAQ:NCSM) last released its quarterly earnings results on Monday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.03). NCS Multistage had a net margin of 2.42% and a return on equity of 2.22%. The company had revenue of $55.96 million during the quarter, compared to analyst estimates of $58.92 million. analysts expect that NCS Multistage Holdings Inc will post 0.2 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/12/14/citadel-advisors-llc-purchases-new-stake-in-ncs-multistage-holdings-inc-ncsm.html.

About NCS Multistage

NCS Multistage Holdings, Inc is a provider of engineered products and support services for oil and natural gas well completions and field development strategies. The Company’s products and services include Multistage Unlimited, casing-installed sliding sleeves, downhole frac isolation assembly, AirLock casing buoyancy system and liner hanger systems.

Institutional Ownership by Quarter for NCS Multistage (NASDAQ:NCSM)

Receive News & Stock Ratings for NCS Multistage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCS Multistage and related stocks with our FREE daily email newsletter.